| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |